GPC3 and hepatocellular carcinoma: Compared with GPC3 or other independent gene signatures, the diagnosis efficiency of DP.eHCC in our study greatly improved in 826 cases of early HCC patients (AUC = 0.956; 95% CI: 0.941–0.972; p < 0.001).